Irati
Garmendia Iturbe
Investigadora ata 2019
Diego
Serrano Tejero
Colaborador Docente
Publicacións nas que colabora con Diego Serrano Tejero (2)
2022
-
YES1 Is a Druggable Oncogenic Target in SCLC
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403
2021
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3